相似文献
1
A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.
Nucleosides Nucleotides. 1998 Jun;17(6):969-85. doi: 10.1080/07328319808004215.
2
A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
Nucleosides Nucleotides Nucleic Acids. 2004;23(1-2):471-81. doi: 10.1081/ncn-120028340.
3
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9. doi: 10.1007/pl00005131.
4
Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.
Br J Pharmacol. 1996 Nov;119(6):1286-90. doi: 10.1111/j.1476-5381.1996.tb16035.x.
5
Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
Biochem Pharmacol. 1998 Mar 1;55(5):627-33. doi: 10.1016/s0006-2952(97)00512-1.
6
An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.
Br J Pharmacol. 1997 Oct;122(3):546-50. doi: 10.1038/sj.bjp.0701401.
7
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Biochem Pharmacol. 1999 Jan 1;57(1):65-75. doi: 10.1016/s0006-2952(98)00298-6.
8
Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
J Med Chem. 1998 Aug 13;41(17):3174-85. doi: 10.1021/jm980147p.
9
Relative agonist potencies of C2-substituted analogues of adenosine: evidence for adenosine A2B receptors in the guinea pig aorta.
Eur J Pharmacol. 1992 Jun 5;216(2):235-42. doi: 10.1016/0014-2999(92)90365-b.
10
Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
Br J Pharmacol. 1994 Jan;111(1):191-8. doi: 10.1111/j.1476-5381.1994.tb14043.x.
引用本文的文献
1
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A Adenosine Receptors.
Drug Dev Res. 1999 May;47(1):45-53. doi: 10.1002/(sici)1098-2299(199905)47:1<45::aid-ddr6>3.0.co;2-u.
2
Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A adenosine receptor antagonists.
Biochem Pharmacol. 2022 Jun;200:115027. doi: 10.1016/j.bcp.2022.115027. Epub 2022 Apr 6.
3
A Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.
Drug Dev Res. 1998 Nov-Dec;45(3-4):113-124. doi: 10.1002/(SICI)1098-2299(199811/12)45:3/4<113::AID-DDR5>3.0.CO;2-S. Epub 1999 Mar 1.
4
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.
Int J Mol Sci. 2019 Nov 3;20(21):5475. doi: 10.3390/ijms20215475.
5
The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion.
Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G397-405. doi: 10.1152/ajpgi.00087.2011. Epub 2011 Oct 28.
6
Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor.
Biochem Pharmacol. 2010 Jul 15;80(2):188-96. doi: 10.1016/j.bcp.2010.03.020. Epub 2010 Mar 25.
7
AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.
Basic Res Cardiol. 2010 Jan;105(1):129-37. doi: 10.1007/s00395-009-0056-9.
8
Recent improvements in the development of A(2B) adenosine receptor agonists.
Purinergic Signal. 2009 Mar;5(1):3-19. doi: 10.1007/s11302-009-9140-8. Epub 2009 Jan 31.
9
Recent improvements in the development of A(2B) adenosine receptor agonists.
Purinergic Signal. 2008 Dec;4(4):287-303. doi: 10.1007/s11302-008-9097-z. Epub 2008 Apr 29.
10
Probing distal regions of the A2B adenosine receptor by quantitative structure-activity relationship modeling of known and novel agonists.
J Med Chem. 2008 Apr 10;51(7):2088-99. doi: 10.1021/jm701442d. Epub 2008 Mar 6.
本文引用的文献
1
2
Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.
Br J Pharmacol. 1996 Nov;119(6):1286-90. doi: 10.1111/j.1476-5381.1996.tb16035.x.
3
N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.
J Med Chem. 1996 Mar 29;39(7):1463-71. doi: 10.1021/jm950267m.
4
Inhibition of human monocyte TNF production by adenosine receptor agonists.
Life Sci. 1993;52(24):1917-24. doi: 10.1016/0024-3205(93)90632-d.
5
Functional characterization of three adenosine receptor types.
Br J Pharmacol. 1993 Jul;109(3):693-8. doi: 10.1111/j.1476-5381.1993.tb13629.x.
6
Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system.
Biochem Biophys Res Commun. 1994 Jan 28;198(2):626-31. doi: 10.1006/bbrc.1994.1091.
7
Molecular cloning and characterization of the human A3 adenosine receptor.
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9. doi: 10.1073/pnas.90.21.10365.
8
Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts.
Biochem Pharmacol. 1994 Mar 2;47(5):801-14. doi: 10.1016/0006-2952(94)90480-4.
9
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
J Med Chem. 1994 Mar 4;37(5):636-46. doi: 10.1021/jm00031a014.
10
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
J Med Chem. 1994 Oct 14;37(21):3614-21. doi: 10.1021/jm00047a018.
Zotero 插件